focus -WSS

focus

author：fashion 2025-09-27 23:32:25 - browse：3882

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

WSS

The Readout: Lenmeldy, GLP

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Trump pressured former Arizona governor to overturn 2020 election results: Sources

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Leon Gautier, last member of French D

Churchill Downs extends trainer Bob Baffert's ban through 2024

hotspot

focus

hotspot

Continuity nursing helped my family in our darkest PICU moments

Why the world’s most expensive drug might be worth the price

23andMe had bad news about my health. I wish a person had delivered it

NASA releases new images of 'fingerprint

Walensky prepares to leave CDC — and Congress — behind

Merck drug for rare lung condition set for approval in U.S.

Medical records are filled with copy

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Hepatitis C has a cure — but many Americans still lack access to it

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

knowledge

A timeline of the missing Titanic tourist submersible

States should stop sabotaging methadone treatment reform

Covid vaccine financial winners and losers, from Pfizer to Novavax

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

EU climate chief is concerned over the expansion of the coal industry in China

Roche subsidiary Foundation Medicine opens new headquarters

hotspot

entertainment

hotspot

entertainment